World Real-World Usage of Nintedanib for PPF Differs From Trial Settings November 30, 2025 11:03 pm Jared Kaltwasser 0 Min Read SHARE New research shows patients commonly take lower doses of nintedanib, and the majority are also taking immunomodulatory drugs. This post was originally published on this site Previous Article TWE writes $687 million off US business value Next Article Netanyahu requests a pardon to end his ongoing corruption trial in Israel
